CASI Pharmaceuticals, Inc (DE) reports

Company Names, identifiers, and filing context for this profile. 1 identity field
Company location
Rockville, MD
SEC filing record 1 source field available
Fiscal year end
31 December
CASI Pharmaceuticals, Inc (DE) has filed 947 SEC EDGAR filings since 14 May 1996

SEC filing history

Showing 101-125 of 580 matching filings.

Per page
25
Current page
5
SC 13G File 005-46247

CONSONANCE CAPITAL MANAGEMENT LP

Filing date
17 Feb 2021
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
SC 13G File 005-46247

CONSONANCE CAPITAL MANAGEMENT LP

Filing date
16 Feb 2021
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
SC 13G File 005-46247

SC 13G filing

Filing date
12 Feb 2021
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
10-Q/A File 000-20713

FORM 10-Q/A

Filing date
10 Feb 2021
Reporting date
30 Sep 2020
Next action
Verify source filing
SC 13D/A File 005-46247

SCHEDULE 13D/A

Filing date
03 Feb 2021
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4

Filing date
23 Dec 2020
Reporting date
22 Dec 2020
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4

Filing date
18 Dec 2020
Reporting date
16 Dec 2020
SEC evidence
Open document Open filing
Next action
Verify source filing
3

FORM 3

Filing date
18 Dec 2020
Reporting date
16 Dec 2020
SEC evidence
Open document Open filing
Next action
Verify source filing
EFFECT File 333-250801

EFFECT filing

Filing date
02 Dec 2020
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
CORRESP

CORRESP filing

Filing date
30 Nov 2020
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
UPLOAD

UPLOAD filing

Filing date
27 Nov 2020
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
4

OWNERSHIP DOCUMENT

Filing date
24 Nov 2020
Reporting date
20 Nov 2020
SEC evidence
Open document Open filing
Next action
Verify source filing
S-3 File 333-250801

FORM S-3

Filing date
20 Nov 2020
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .